CPC A61K 9/0053 (2013.01) [A61K 9/0095 (2013.01); A61K 9/10 (2013.01); A61K 31/366 (2013.01); A61K 31/40 (2013.01); A61K 31/505 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61K 47/22 (2013.01); A61K 47/24 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01)] | 13 Claims |
1. An aqueous suspension for oral administration, consisting of:
atorvastatin in an amount of about 4 mg/ml;
a suspending agent in an amount of about 2% w/w comprising carboxymethyl cellulose sodium in an amount of about 0.7% w/w and magnesium aluminum silicate in an amount of about 1.3% w/w;
one or more pharmaceutically acceptable excipients selected from the group consisting of a co-solvent, a preservative, a sweetener, a buffer, and a flavoring agent;
and
a vehicle comprising water, wherein the atorvastatin has a d90 particle size of from 1 μm to 15 μm.
|